OrthoPediatrics (NASDAQ:KIDS) Sets New 1-Year High – Should You Buy?

OrthoPediatrics Corp. (NASDAQ:KIDS) shares hit a new 52-week high on Wednesday . The stock traded as high as $24.56 and last traded at $24.24, with a volume of 231374 shares. The stock had previously closed at $23.28.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. Piper Sandler reiterated an “overweight” rating and issued a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a report on Wednesday, August 5th. Weiss Ratings upgraded OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. Truist Financial set a $22.00 price objective on OrthoPediatrics in a report on Wednesday, August 5th. BTIG Research reaffirmed a “buy” rating and issued a $24.00 price objective on shares of OrthoPediatrics in a research note on Friday, May 1st. Finally, Needham & Company LLC boosted their target price on OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Nine investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, OrthoPediatrics has an average rating of “Moderate Buy” and an average price target of $25.89.

OrthoPediatrics Price Performance

The company has a debt-to-equity ratio of 0.28, a current ratio of 4.78 and a quick ratio of 2.17. The company’s 50-day simple moving average is $19.97 and its 200-day simple moving average is $18.07. The company has a market cap of $653.01 million, a price-to-earnings ratio of -14.89 and a beta of 0.98.

OrthoPediatrics (NASDAQ:KIDS) last posted its earnings results on Tuesday, August 4th. The company reported ($0.26) EPS for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.04. The business had revenue of $70.51 million for the quarter, compared to analysts’ expectations of $68.21 million. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. On average, equities research analysts anticipate that OrthoPediatrics Corp. will post -1.14 EPS for the current year.

Hedge Funds Weigh In On OrthoPediatrics

A number of institutional investors and hedge funds have recently added to or reduced their stakes in KIDS. Russell Investments Group Ltd. grew its stake in shares of OrthoPediatrics by 433.1% during the third quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock valued at $26,000 after acquiring an additional 1,139 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in OrthoPediatrics by 5,226.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock valued at $46,000 after purchasing an additional 2,561 shares during the last quarter. Caption Management LLC purchased a new position in OrthoPediatrics in the third quarter valued at about $54,000. BNP Paribas Financial Markets grew its stake in OrthoPediatrics by 60.2% during the 3rd quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock valued at $61,000 after purchasing an additional 1,235 shares in the last quarter. Finally, State of Wyoming grew its stake in OrthoPediatrics by 189.7% during the 4th quarter. State of Wyoming now owns 6,822 shares of the company’s stock valued at $121,000 after purchasing an additional 4,467 shares in the last quarter. 69.05% of the stock is owned by hedge funds and other institutional investors.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.